Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19463633.
- Also identified by DOI 10.1016/j.athoracsur.2008.11.034.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve (Edwards Lifesciences, Irvine, CA).
Medical subject headings
- Aortic Valve Stenosis
- Bioprosthesis
- Cardiac Catheterization
- Heart Valve Prosthesis
- Postoperative Complications